The first US Food and Drug Administration-approved gene therapy for an inherited disorder will cost you $425,000 per eye.
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
23andMe have announced a large-scale study designed to uncover the genetic reasons why people respond differently to diet and exercise regimes.
Recent revelations that a U.S. researcher injected Americans with his experimental herpes vaccine without routine safety oversight raised an uproar among scientists and ethicists.
The nausea, and nasty symptoms that come hand in hand with chemotherapy could soon no longer exist, after a recent experiment looks at using sperm to deliver cancer drugs.
Companion DX is one of at least six clinical labs mired in bankruptcy court after Medicare alleged they improperly billed the government for unnecessary tests.
The spread of some STI’s could potentially be dramatically reduced by instructing people to take antibiotics within 24 hours after unprotected sex.
Although the promise of stem cell therapy didn’t fulfill some of its early promises, two small companies are quietly working to change that.
A team of scientists are attempting to use CRISPR to copy unique mutations from affected children into pigs, who are suffering from a genetic disorder.
The Human Rights Watch has questionned the motives behind Chinese authorities collecting DNA samples from the Xinjiang region.
British doctors have seen a breakthrough in heamophilia A, a genetic defect that sees patients not producing a protein to stop bleeding.
California cherry growers are relying on gene-drive technology to eradicate the fly species that is costing US agriculture $700 million a year.
CRISPR Therapeutics is pioneering a new class of medicines, to conduct the first company-sponsored clinical trial of a CRISPR gene-edited therapy.
Those women at the highest risk of aggressive breast cancers may need a more personalised approach to treatment, rather than just mammograms.